Literature DB >> 8313588

Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

A S Dajani1, K A Taubert, M Takahashi, F Z Bierman, M D Freed, P Ferrieri, M Gerber, S T Shulman, A W Karchmer, W Wilson.   

Abstract

Long-term management of patients with Kawasaki disease should be tailored to the degree of coronary arterial involvement. This committee has made recommendations for each risk level about antiplatelet and anticoagulant therapy, physical activity, follow-up assessment by a pediatric cardiologist or primary care physician, and the appropriate diagnostic procedures that may be performed to evaluate cardiac disease. The risk level for a given patient with coronary arterial involvement may change over time because of changes in coronary artery morphology. The recommendations for management presented here are intended as practical interim guidelines until additional prospective or retrospective data are compiled to define more clearly the natural history of Kawasaki disease.

Entities:  

Mesh:

Year:  1994        PMID: 8313588     DOI: 10.1161/01.cir.89.2.916

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  Recognition and management of Kawasaki disease.

Authors:  R K Han; B Sinclair; A Newman; E D Silverman; G W Taylor; P Walsh; B W McCrindle
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

2.  Kawasaki Disease.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

3.  Kawasaki disease in India.

Authors:  Bhagyavathy Bagyaraj; Usha Krishnan; Farida Farzana
Journal:  Indian J Pediatr       Date:  2003-11       Impact factor: 1.967

4.  Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules.

Authors:  Luiza Guilherme; Martha P Alba; Frederico Moraes Ferreira; Sandra Emiko Oshiro; Fabio Higa; Manuel E Patarroyo; Jorge Kalil
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

Review 5.  From atherosclerotic coronary ectasia to aneurysm: a case report and literature review.

Authors:  Gunnar Plehn; Marc van Bracht; Christian Zuehlke; Max Olav Schrage; Ingo Wickenbrock; Christian Perings; Hans-Joachim Trappe
Journal:  Int J Cardiovasc Imaging       Date:  2005-11-04       Impact factor: 2.357

6.  Giant coronary aneurysms caused by Kawasaki disease.

Authors:  Robert Sabiniewicz; Julita Switońska; Jan Ereciński
Journal:  Pediatr Cardiol       Date:  2010-02-27       Impact factor: 1.655

Review 7.  Kawasaki disease: an update.

Authors:  G K Singh
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

8.  Recognizing Kawasaki disease.

Authors:  B Lang
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

Review 9.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

10.  Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification.

Authors:  Chantale Lapierre; Audrey Bitsch; Ronald Guérin; Laurent Garel; Joaquim Miró; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2009-09-26       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.